Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meyer-Monard

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Therapeutische Umschau. Revue Therapeutique|May 13, 2006
[Genetic diagnosis of acute leukemias--a practical guide]S Meyer-Monard
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1995
AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activityJ Nakagawa, H Waldner, S Meyer-Monard, et al.
Anticancer Research|December 17, 1998
The calcium-binding protein calretinin-22k is detectable in the serum and specific cells of cancer patientsB Schwaller, S Meyer-Monard, J C Gander, et al.
Leukemia|October 15, 2005
Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID miceU Siegler, C P Kalberer, P Nowbakht, et al.
Cytokines, Cellular & Molecular Therapy|June 1, 1997
G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8; 21) translocation: basis for potential therapeutic efficacyN Da Silva, S Meyer-Monard, M L Menot, et al.
Leukemia|October 1, 2004
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantationJ R Passweg, A Tichelli, S Meyer-Monard, et al.
Bone Marrow Transplantation|September 5, 2002
High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantationJ R Passweg, S Meyer-Monard, M Gregor, et al.
Leukemia & Lymphoma|August 13, 2009
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)R Zenhäusern, S-F Hsu Schmitz, M Solenthaler, et al.
Leukemia|January 13, 2006
Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemiaS Meyer-Monard, V Parlier, J Passweg, et al.
International Journal of Laboratory Hematology|August 27, 2009
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral bloodA Rovó, G Stüssi, S Meyer-Monard, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Therapeutische Umschau. Revue Therapeutique|May 13, 2006
[Genetic diagnosis of acute leukemias--a practical guide]S Meyer-Monard
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1995
AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activityJ Nakagawa, H Waldner, S Meyer-Monard, et al.
Anticancer Research|December 17, 1998
The calcium-binding protein calretinin-22k is detectable in the serum and specific cells of cancer patientsB Schwaller, S Meyer-Monard, J C Gander, et al.
Leukemia|October 15, 2005
Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID miceU Siegler, C P Kalberer, P Nowbakht, et al.
Cytokines, Cellular & Molecular Therapy|June 1, 1997
G-CSF activates STAT pathways in Kasumi-1 myeloid leukemic cells with the t(8; 21) translocation: basis for potential therapeutic efficacyN Da Silva, S Meyer-Monard, M L Menot, et al.
Leukemia|October 1, 2004
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantationJ R Passweg, A Tichelli, S Meyer-Monard, et al.
Bone Marrow Transplantation|September 5, 2002
High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantationJ R Passweg, S Meyer-Monard, M Gregor, et al.
Leukemia & Lymphoma|August 13, 2009
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)R Zenhäusern, S-F Hsu Schmitz, M Solenthaler, et al.
Leukemia|January 13, 2006
Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemiaS Meyer-Monard, V Parlier, J Passweg, et al.
International Journal of Laboratory Hematology|August 27, 2009
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral bloodA Rovó, G Stüssi, S Meyer-Monard, et al.
Pageof 2